03/29/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
10:02 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
3:31 PM | Deep Track Capital, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
03/20/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:31 PM | Olema Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
3:15 PM | Olema Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
4:36 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/04/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
1:26 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:53 AM | Kynam Capital Management, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:16 PM | Olema Pharmaceuticals (Filer)
| Form 424B3 | |
02/12/2024
11:21 AM | JANUS HENDERSON GROUP PLC (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/11/2024
11:15 PM | Olema Pharmaceuticals (Filer)
| Form EFFECT | |
02/05/2024
4:30 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
2:24 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
1:58 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
01/29/2024
6:30 AM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:30 AM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
8:07 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:18 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:25 PM | Olema Pharmaceuticals (Filer)
| Form 424B5 | |
01/05/2024
4:26 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:30 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
3:19 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 3/A | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
6:48 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:15 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
4:15 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
9:20 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
6:00 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
11/22/2023
6:00 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
2:25 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:04 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:12 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:35 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:11 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:16 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:49 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:52 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
8:39 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:53 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:50 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:46 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:21 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:49 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023
9:38 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023
6:45 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:46 PM | Olema Pharmaceuticals (Filer)
| Form 8-K/A | |
10/17/2023
3:42 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2023
3:43 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
6:33 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:17 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
10:05 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
4:12 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
3:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/14/2023
3:25 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:14 PM | Olema Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/13/2023
4:22 PM | Olema Pharmaceuticals (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
09/05/2023
8:08 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:05 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4/A | |
09/05/2023
12:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
6:39 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:37 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
11:22 AM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
1:54 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:36 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
3:40 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
3:49 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
6:14 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | BUTITTA CYNTHIA M (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Hrustanovic Gorjan (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Horning Sandra (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Larson Yi (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | CLARK IAN T (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:31 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
06/14/2023
3:23 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
3:28 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
4:53 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:58 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
2:19 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
5:22 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
4:31 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
